CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 74 enrolled
Drug / intervention
Questionnaires completion +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02774213
NCT02774213N/ACompleted

An Observational Study to Collect Data Characterizing Analgesia in Patients Suffering From Bone Metastasis Induced Pain

Tools4Patient·observational·Posted May 17, 2016·Updated Aug 19, 2019

In Brief

An observational study evaluating Questionnaires completion and Clinical Pain Assessments for Bone Metastasis. Completed, enrolled 74 participants across 8 sites in 2 countries.

Detailed Summary

Up to 180 patients with bone metastasis and requiring analgesic treatment will be followed during 4 to 10 weeks. All patients will continue to receive their cancer therapeutic treatments and be treated for pain relief exactly as they would normally be by the Investigator based on their needs. During their regular visits to the Investigator, patients will complete questionnaires and Clinical Pain Assessments.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBone Metastasis
CountriesBelgium, France
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMay 17, 2016
Enrollment StartJul 1, 2014
Primary CompletionApr 28, 2017
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 10.1 years ago

Interventions

Questionnaires completionother

Clinical Pain Assessmentsother